查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1611944

病理學人工智慧市場：按組件、神經網路、應用程式和最終用戶分類 - 2025-2030 年全球預測

AI in Pathology Market by Component (Hardware, Software), Neural Network (Convolutional neural networks (CNNs), Generative adversarial networks (GANs), Recurrent neural networks (RNNs)), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，病理學領域的人工智慧市場價值為2,901萬美元，預計到2024年將達到3,336萬美元，複合年成長率為15.33%，預計到2030年將達到7,875萬美元。

病理學領域的人工智慧 (AI) 透過提高診斷準確性、效率和個人化患者照護正在徹底改變醫療保健產業。該領域利用機器學習演算法和影像分析工具進行自動化和半自動化病理評估。病理學對人工智慧的需求源於診斷程序日益複雜、高通量篩檢的需求以及全球病理學家的短缺。應用包括數位病理學、組織分析、疾病檢測和預後評估，最終用戶包括醫院、診斷實驗室和研究機構。

主要市場統計
基準年[2023] 2901萬美元
預測年份 [2024] 3336萬美元
預測年份 [2030] 7875萬美元
複合年成長率（%） 15.33%

計算技術的進步、人工智慧在醫療保健領域的日益採用以及對精準醫療的日益關注推動了市場成長。人工智慧技術的整合將有助於早期疾病檢測、提高工作流程效率並推動需求。然而，資料隱私問題、高昂的實施成本以及缺乏標準化的法規結構構成了重大挑戰。該行業正受益於深度學習和巨量資料分析等技術增強，這些技術促進了準確的模式識別和預測分析。政府和私人實體投資於醫療保健數位化和人工智慧研究將進一步推動市場擴張。

新的發展機會在於科技公司和醫療保健提供者之間的合作，開發客製化的人工智慧解決方案。鼓勵監管機構制定明確的指導方針，以加速人工智慧的採用。開發具有更高可解釋性和即時分析能力的人工智慧平台創新的市場已經成熟。然而，患者照護中人工智慧決策的互通性問題和倫理問題等挑戰仍然至關重要。由於市場是動態的，並且持續的研發工作專注於改進超越人類診斷能力的人工智慧演算法，相關人員可以期待豐厚的投資收益。對增強各種醫療保健系統之間資料整合的創新的追求以及對可解釋人工智慧的重視為未來的成長和競爭優勢提供了一條充滿希望​​的道路。

市場動態：揭示病理學市場快速發展的人工智慧的關鍵市場洞察

供需的動態交互作用正在改變病理學領域的人工智慧市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球病理數位化的進展
    • 由於慢性病的傳播，對遠距病理學的需求不斷成長
  • 市場限制因素
    • 病理學人工智慧相關的高成本
  • 市場機會
    • 病理學人工智慧的技術進步
    • 對個人化和客製化醫療的需求不斷增加
  • 市場挑戰
    • 資料隱私問題

波特五力：駕馭病理學人工智慧市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對病理學市場人工智慧的影響

外部宏觀環境因素在塑造病理學市場人工智慧的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解病理學 AI 市場的競爭格局

對病理學市場中人工智慧的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣病理市場 AI 供應商的績效評估

FPNV 定位矩陣是評估病理學市場人工智慧供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

為策略分析和推薦病理學繪製人工智慧市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對病理學市場中的人工智慧進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地病理學數位化取得進展
      • 由於慢性病的傳播，對遠距病理學的需求不斷增加
    • 抑制因素
      • 病理學人工智慧相關的高成本
    • 機會
      • 病理學人工智慧的技術進步
      • 對個人化和客製化醫療保健的需求不斷成長
    • 任務
      • 資料隱私問題
  • 市場區隔分析
    • 組件：廣泛的病理學軟體應用程式，可實現無縫工作流程和高效資料管理
    • 神經網路：提高診斷準確性和效率將增加生成對抗網路的採用
    • 應用：廣泛利用AI在病理領域進行疾病診斷，促進疾病早期發現
    • 最終用戶：在製藥和生物技術公司中擴展病理學人工智慧以實現潛在的治療發現
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章病理學人工智慧市場：按組成部分

  • 硬體
  • 軟體

第7章病理學中的人工智慧市場神經網路

  • 卷積類神經網路（CNN）
  • 生成對抗網路（GAN）
  • 循環神經網路 (RNN)

第8章病理學人工智慧市場：按應用分類

  • 臨床工作流程
  • 疾病診斷與預後
  • 藥物發現
  • 培訓和教育

第 9 章病理學人工智慧市場：按最終用戶分類

  • 學術研究所
  • 醫院
  • 製藥和生物技術公司

第 10 章：美洲病理學人工智慧市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區病理學人工智慧市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章：歐洲、中東和非洲病理學人工智慧市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 微軟協助打造全球最大的病理學和腫瘤學成像人工智慧
    • PathAI 推出 PathExplore，這是一款由人工智慧驅動的病理學面板，可從腫瘤微環境中解鎖開拓的見解
    • Page 和 Leica Biosystems 宣布擴大合作夥伴關係，以加強影像管理和人工智慧技術在全球數位病理工作流程中的使用
  • 戰略分析和建議

公司名單

  • aetherAI
  • Aiforia Technologies Oyj
  • Akoya Biosciences, Inc.
  • Deep Bio, Inc.
  • Evident Corporation
  • F. Hoffmann-La Roche Ltd.
  • Ibex Medical Analytics Ltd.
  • Indica Labs, Inc.
  • Inspirata, Inc.
  • LUMEA, Inc.
  • MindPeak GmbH
  • Nucleai Inc.
  • OptraSCAN Inc.
  • Paige.AI, Inc.
  • PathAI, Inc.
  • Proscia Inc.
  • Techcyte, Inc.
  • Tempus Labs, Inc.
  • Tribun Health
  • Visikol, Inc. by CELLINK
  • Visiopharm A/S
Product Code: MRR-1730A405FA4B

The AI in Pathology Market was valued at USD 29.01 million in 2023, expected to reach USD 33.36 million in 2024, and is projected to grow at a CAGR of 15.33%, to USD 78.75 million by 2030.

Artificial Intelligence (AI) in pathology is revolutionizing the healthcare industry by enhancing diagnostic accuracy, efficiency, and personalized patient care. The field involves leveraging machine learning algorithms and image analysis tools for automated and semi-automated pathological assessments. The necessity of AI in pathology arises from the increasing complexity of diagnostic procedures, the demand for high-throughput screening, and the global shortage of trained pathologists. Applications encompass digital pathology, tissue analysis, disease detection, and prognosis assessment, with end-users including hospitals, diagnostic laboratories, and research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 29.01 million
Estimated Year [2024] USD 33.36 million
Forecast Year [2030] USD 78.75 million
CAGR (%) 15.33%

Market growth is propelled by advancements in computational technologies, increasing adoption of AI in healthcare, and a growing focus on precision medicine. The integration of AI technologies aids in early disease detection and improves workflow efficiency, driving demand. However, data privacy concerns, high implementation costs, and lack of standardized regulatory frameworks pose significant challenges. The sector benefits from technological enhancements such as deep learning and big data analytics, which facilitate precise pattern recognition and predictive analytics. Governments and private entities investing in healthcare digitization and AI research further energize market expansion.

Emerging opportunities lie in collaborative ventures between tech companies and healthcare providers to develop tailored AI solutions. Regulatory bodies are encouraged to establish clear guidelines to accelerate AI adoption. The market is ripe for innovation in developing AI platforms with higher interpretability and real-time analytical capabilities. However, overcoming challenges such as interoperability issues and ethical concerns regarding AI decision-making in patient care remains critical. The market is dynamic, with continuous R&D efforts focused on refining AI algorithms to surpass human diagnostic capabilities, thus ensuring significant returns on investment for stakeholders. The pursuit of innovations that enhance data integration across various healthcare systems and the emphasis on explainable AI represent promising avenues for future growth and competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving AI in Pathology Market

The AI in Pathology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing digitalization of pathology worldwide
    • Growing need for telepathology with the prevalence of chronic disease
  • Market Restraints
    • High cost associated with AI in pathology
  • Market Opportunities
    • Technological advancements in AI in pathology
    • Rising demand for personalized and customized medicine
  • Market Challenges
    • Concerns associated with data privacy

Porter's Five Forces: A Strategic Tool for Navigating the AI in Pathology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the AI in Pathology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the AI in Pathology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the AI in Pathology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the AI in Pathology Market

A detailed market share analysis in the AI in Pathology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the AI in Pathology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the AI in Pathology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the AI in Pathology Market

A strategic analysis of the AI in Pathology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the AI in Pathology Market, highlighting leading vendors and their innovative profiles. These include aetherAI, Aiforia Technologies Oyj, Akoya Biosciences, Inc., Deep Bio, Inc., Evident Corporation, F. Hoffmann-La Roche Ltd., Ibex Medical Analytics Ltd., Indica Labs, Inc., Inspirata, Inc., LUMEA, Inc., MindPeak GmbH, Nucleai Inc., OptraSCAN Inc., Paige.AI, Inc., PathAI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, Visikol, Inc. by CELLINK, and Visiopharm A/S.

Market Segmentation & Coverage

This research report categorizes the AI in Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Hardware and Software.
  • Based on Neural Network, market is studied across Convolutional neural networks (CNNs), Generative adversarial networks (GANs), and Recurrent neural networks (RNNs).
  • Based on Application, market is studied across Clinical Workflow, Disease Diagnosis & Prognosis, Drug Discovery, and Training & Education.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals, and Pharmaceuticals & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing digitalization of pathology worldwide
      • 5.1.1.2. Growing need for telepathology with the prevalence of chronic disease
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with AI in pathology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in AI in pathology
      • 5.1.3.2. Rising demand for personalized and customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Extensive software applications in pathology for seamless workflows and efficient data management
    • 5.2.2. Neural Network: Increasing generative adversarial networks adoption due to diagnostic accuracy and efficiency
    • 5.2.3. Application: Wide utilization of AI in pathology for disease diagnosis to facilitate early detection of diseases
    • 5.2.4. End-User: Expansion of pathology AI in pharmaceuticals & biotechnology companies for discovering potential therapeutics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. AI in Pathology Market, by Component

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software

7. AI in Pathology Market, by Neural Network

  • 7.1. Introduction
  • 7.2. Convolutional neural networks (CNNs)
  • 7.3. Generative adversarial networks (GANs)
  • 7.4. Recurrent neural networks (RNNs)

8. AI in Pathology Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Workflow
  • 8.3. Disease Diagnosis & Prognosis
  • 8.4. Drug Discovery
  • 8.5. Training & Education

9. AI in Pathology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals
  • 9.4. Pharmaceuticals & Biotechnology Companies

10. Americas AI in Pathology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific AI in Pathology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa AI in Pathology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Microsoft Collab to Build World's Largest Pathology, Oncology Imaging AI
    • 13.3.2. PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment
    • 13.3.3. Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. aetherAI
  • 2. Aiforia Technologies Oyj
  • 3. Akoya Biosciences, Inc.
  • 4. Deep Bio, Inc.
  • 5. Evident Corporation
  • 6. F. Hoffmann-La Roche Ltd.
  • 7. Ibex Medical Analytics Ltd.
  • 8. Indica Labs, Inc.
  • 9. Inspirata, Inc.
  • 10. LUMEA, Inc.
  • 11. MindPeak GmbH
  • 12. Nucleai Inc.
  • 13. OptraSCAN Inc.
  • 14. Paige.AI, Inc.
  • 15. PathAI, Inc.
  • 16. Proscia Inc.
  • 17. Techcyte, Inc.
  • 18. Tempus Labs, Inc.
  • 19. Tribun Health
  • 20. Visikol, Inc. by CELLINK
  • 21. Visiopharm A/S

LIST OF FIGURES

  • FIGURE 1. AI IN PATHOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. AI IN PATHOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AI IN PATHOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AI IN PATHOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS (CNNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS (GANS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY RECURRENT NEURAL NETWORKS (RNNS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CLINICAL WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS & PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023